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NOTICES 
Brief notices of interest to a substantial number of our readers are published in GASTROENTEROLOGY. Notices must be typewritten 
double-spaced and submitted in triplicate. Notices received less than 5 months before the issue of publication cannot be 
guaranteed an appropriate publication date. Direct all Notices to: Nicholas F. LaRusso, M.D., Editor, GASTROENTEROLOGY, Mayo 
Foundation, 200 First Street S.W., Rochester, Minnesota 55905. 
FALK SYMPOSIA NOS. 72 AND 73 
Symposium 72, " I V International Symposium on Inflammatory 
Bowel Diseases," will take place September 6-8, 1993. "Short 
Chain Fatty Acids," symposium 73, wil l be held September 9-11, 
1993. Both congresses will be in Strasbourg, Germany. 
Contact: Falk Foundation e.V., Leinenweberstraße 5, W-7800 
Freiburg, Germany; or call (49) 761-13034-0; or fax (49) 761-
13034-59. 
SECOND INTERNATIONAL CONFERENCE 
OF GASTROENTEROLOGY 
This conference will be held in Hong Kong August 27-29, 
1993, and in Chengdu August 27-September 2, 1993. 
For information and application, please contact: Conference Se-
cretariat, Room 1611-13, World Finance Center, North Tower, 
Harbour City, Kowloon, Hong Kong; or call (852) 736-7837; or 
fax (852) 376-0329. 
INTERNATIONAL CONFERENCE ON 
ENDOTOXINS AMSTERDAM IV 
This conference will take place in Amsterdam, The Nether-
lands, August 17-20, 1993. 
Contact: Dr. S. j . H. van Deventer, Conference Secretary, De-
partment of Hematology (G-l-112), Academic Medical Center, 
Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; or call 
(31) 20-5669111; or fax 09 (31) 20-5664440. 
THE AGA 1993 FALL POSTGRADUATE COURSE 
The topic for this course is "A Comprehensive Update and Re-
view of Gastroenterology and Hepatology." It wil l be held Sep-
tember 9-12, 1993, in Chicago, Illinois. CME Credit (24.5 hours, 
Category I) wil l be offered. 
Contact: Registration Manager, SLACK Incorporated, 6900 
Grove Road, Thorofare, New Jersey 08086-9447; or call (609) 
848-1000; or fax (609) 848-5274. 
THE LEEDS COURSE IN CLINICAL NUTRITION 
This event wil l take place September 7-10, 1993, in Leeds, En-
gland. 
Contact: Mrs. Hilary L. Helme, Dept of Continuing Profes-
sional Education, Continuing Education Building, Springfield 
Mount, Leeds LS2 9NG, England; or call (44) 532-333233. 
SECOND ANNUAL SCIENTIFIC MEETING OF THE 
DYSPHAGIA RESEARCH SOCIETY 
Abstracts of scientific works in physiology/pathophysiology of 
swallowing and dysphagia-related topics are invited for presenta-
tion. This meeting will be held October 22-24, 1993, in Lake 
Geneva, Wisconsin. Deadline for submission of abstracts is Sep-
tember 1, 1993. 
Contact: Dysphagia Research Society, Administrative Office, 
c/o Reza Shaker, M.D. , GI Section/11 IC, VA Medical Center, 
5000 West National Avenue, Milwaukee, Wisconsin 53295; or call 
(414) 384-2000, ext 6943; or fac (414) 384-8480. 
14TH INTERNATIONAL CONGRESS OF LYMPHOLOGY 
The following conferences will be held in Washington, D.C. 
"Frontiers in Lymphology" (Part 1) will be held September 20-21, 
1993, and "Lymphology in 1993" (Part 2) will be held September 
22-26, 1993. 
Contact: 14th ICL Congress Secretariat, c/o M. H. Witte, M.D., 
Attention: Grace Wagner, Program Coordinator, Department of 
Surgery/General, University of Arizona College of Medicine, 1501 
North Campbell Avenue, Tucson, Arizona 85724; or call (602) 
626-6118; or fax (602) 626-0822. 
ASPEN BILE ACID/CHOLESTEROL/ 
LIPOPROTEIN CONFERENCE 
This conference will take place August 21-24, 1993 in Aspen, 
Colorado. Deadline for applications is May 30, 1993. 
Contact: Mrs. Bernie C. Kern, 501 Madison Street, Denver, Col-
orado 80206; or call (303) 325-0330; or fax (303) 355-0739. 
15TH ANNUAL ASPEN CONFERENCES 
ON PEDIATRIC DISEASE 
This conference wil l be held July 26-30, 1993, in Aspen, Colo-
rado. Twenty-five hours of Category I credit wil l be offered. 
Contact: Institute for Pediatric Medical Education, 6604 Lan-
don Lane, Bethesda, Maryland 20817; or call/fax (301) 229-8338. 
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Hyperamylasemia, in acute pancreatitis, 
104:1768 
Hyperdynamic circulation, in cirrhosis, 
104:1579-c 
Hyperemia 
mechanism of injury-induced (rat), 
104:114 
in pancreatic exocrine secretion, 
104:672-tmig 
Hypergastrinemia 
carcinoids and, 104:994 
peptic ulcer disease and, 104:1356 
Hyperglycemia, total parenteral nutri-
tion and (rat), 104:235 
Hyperlipidemia, in pancreatitis, 
104:1527-cr, 104:156()-e 
Hyperosmolality, total parenteral nutri-
tion and (rat), 104:235 
Hyperplasia 
liver, 104:616-cr 
neuroendocrine cell, 104:12 
Hyperpolarization 
lower esophageal sphincter and (opos-
sum), 104:1439 
nitric oxide and (dog, human), 104:398 
Hypersensitivity-type reaction 
in Crohn's disease, 104:772 
sulindac-associated hepatic injury and, 
104:569 
Hypertension, cyclosporin A and, 
104:519 
Hypertrophic gastropathy 
carcinoids and, 104:994 
Menetrier's disease and, 104:1310 
Hypertrophic lymphocytic gastritis, 
Menetrier's disease and, 104:1310 
Hypertrophic pyloric stenosis, infantile, 
nitric oxide synthase in, 104:658-ss 
Hypochlorhydria, Helicobacter mustelae in 
feces and (ferret), 104:86 
Hypolactasia, human adult-type, mosaic-
ism of brush border antigens in, 
104:21 
Hypopharynx, deglutitive tongue action 
and, 104:152 
Hyposmie stress, esophageal cell K + 
channels and (rabbit), 104:417 
Hypotension, arterial, captopril-induced, 
104:588 
Hypothalamus 
corticotropin-releasing factor in (rat), 
104:716 
lesions, in gastrointestinal cell prolifer-
ation (rat), 104:475 
1 2 5 I , membrane transport and, 104:1796 
IEC-18 cells, IGF-1 receptor expression 
in (rat), 104:1705 
IgA antigliadin antibodies, in celiac 
disease, 104:1263 
IgG, in gut lavage fluid, 104:1064 
IgM antibodies 
in celiac disease, 104:1263 
to hepatitis B core antigen, 104:549 
to hepatitis F virus, 104:556 
Ileum 
in Crohn's disease, 104:351 
in cryptosporidiosis (pig), 104:440 
cytochrome P450 in (rat), 104:1611 
enterocytes, in active bile acid transport 
(guinea pig, rat), 104:38 
growth, phytohemagglutinin lectin and 
(rat), 104:1669 
perforation, cytomegalovirus and, 
104:1822-cr 
proglucagon gene expression in (rat), 
104:459 
pseudo-obstruction and, 104:1398 
Saccharomyces boulardii inhibition of 'Toxin 
A effects in (rat), 104:1108 
Ileus reversal 
a2-adrenergic drugs for (rat), 104:819 
fedotozone for (rat), 104:724 
Immortalization, of colon epithelium 
(rat), 104:1346 
Immune activation genes, in inflamma-
tory bowel disease, 104:448 
Immune system 
in gastric acid secretion and peptic ulcer 
disease, 104:1874-ss 
macromolecular uptakes in gut and, 
104:622-srr 
Immunocytes, in a-chain disease, 
104:278-cr 
Immunoelectron microscopy, trefoil 
peptides and, 104:12 
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Immunohistochemical analysis 
cytomegalovirus-associated ileal perfo-
ration and, 104:1822-cr 
p53 overexpression and, 104:57 
transforming growth factor a and (rat), 
104:789 
trefoil peptides and, 104:12 
Immunonutrition, enteral nutrition and, 
104:936-ss 
Immunoperoxidasc staining 
endocrine markers and, 104:994 
membrane transport and, 104:1796 
Immunoproliferative small intestinal 
disease (IPSID), celiac disease 
and,104:1887-c 
Indocyanine green, in glomerular filtra-
tion rate assessment, 104:884 
Indomethacin 
for chronic colitis (rat), 104:47 
in experimental colitis, 104:1891 -c 
gastric hyperemia mechanism and (rat), 
104:114 
in cholecystitis (rabbit), 104:248 
in cryptosporidiosis (pig), 104:440 
IL - lß action on intestinal motility and 
(rat), 104:377 
lamina propria mononuclear cells and 
(rat), 104:964 
renal dysfunction induced by, in cir-
rhosis, 104:869 
Infants 
hypertrophic pyloric stenosis in, 
104:658-ss 
pseudo-obstruction in, 104:1398 
total parenteral nutrition-related chole-
stasis and, 104:286-srr 
toxigenic diarrhea in, 104:916-srr 
Infection, in cirrhotics with gastrointesti-
nal hemorrhage, 104:1238-c 
Inferior vena cava, membranous ob-
struction of, 104:1581-c 
Inflammation 
anal transition zone and, 104:514 
in Menetrier's disease, 104:1310 
nitric oxide in (rat), 104:759 
Inflammatory bowel disease (IBD) 
adhesion molecule expression in, 
104:1568-ss 
anemia in, erythropoietin for, 
104:1828-cr 
clustering in, l04:643-e 
cytokines and, 104:1202-e 
diarrhea in, I04:671-tmig, 104:671 
familial, 104:351 
genes in, 104:671-tmig, 104:741 
gut lavage fluids in, 104:1064 
HLA class I I genes in, 104:741 
immune activation genes in, 104:448 
interleukin 1 in, 104:749 
interleukin 2 in (rat), 104:964 
interleukin 6 in, 104:1285 
macrophage-derived mucin secretago-
gue in, 104:1302 
mesalamine for, 104:435 
MHC-restricted cytotoxicity in, 104:384 
muscularis in (rabbit), 104:369 
neutrophils in (rat), 104:953-tmig, 
104:1021 
odd forms of, 104:327-srr 
T cells in, 104:335-tmig, 104:384, 
104:448 
trefoil peptide gene expression in, 
104:12 
Inflammatory cells 
in acute pancreatitis (rat), 104:1498 
in cryptosporidiosis (pig), 104:440 
in hepatitis C virus infection, 104:595 
Inflammatory infiltrate, in pouchitis, 
104:981 
Inflammatory mediators, prostanoids in 
release of from mast cells, 
104:314-e 
Influenza, in Crohn's disease, 104:351 
Inhibitory junction potentials 
of lower esophageal sphincter (opos-
sum), 104:1439 
nitric oxide and (dog, human), 104:398 
m In- labeled granulocyte scanning, of 
inflammatory infiltrate in pouchi-
tis, 104:981 
Inositol triphosphate (IP 3 ) 
in restoration of impaired gallbladder 
motility, 104:563 
tauroursodeoxycholic acid and (rat), 
104:604 
In situ hybridization 
cytomegalovirus-associated ileal perfo-
ration and, 104:1822-cr 
ileal proglucagon gene expression and 
(rat), 104:459 
trefoil peptides and, 104:12 
Insulin 
in amino acid turnover in cirrhosis, 
104:1712 
gallbladder motility and (pig), 104:1680 
ileal proglucagon gene expression and 
(rat), 104:459 
ventromedial hypothalamic lesions and 
(rat), 104:475 
Insulinlike growth factor-binding pro-
tein, in AGS cell growth, 104:1595 
Insulinlike growth factor 1 (IGF-1) 
expression, extracellular matrix effect 
on (rat), 104:1705 
small bowel and (transgenic mice), 
104:973 
Integrins, effect of leumedins on, 
l04:953-tmig 
Interferon, recombinant, for cryptogenic 
chronic active hepatitis, 104:1757 
Interferon alpha 
essential mixed cryoglobulinemia and, 
104:272-cr 
for cirrhosis, 104:953-tmig, 104:1116 
for hepatitis B, 104:595, 104:953-tmig, 
104:1116 
for hepatitis C, 104:580, 595, 104:672-
tmig, 104:877, 104:1472 
Interferon alpha-2a, for hepatitis C, l i -
chen planus and, 104:903-cr 
Interleukin 1 (IL-1) 
in chronic colitis (rat), 104:47 
intestinal, 104:749 
Interleukin l ß (IL-lß) 
acetylcholine release and (rat), 104:1648 
in intestinal motility (rat), 104:377 
Interleukin 2 (IL-2) 
in experimental colitis (rat), 104:964 
in inflammatory bowel disease, 104:448 
in ulcerative colitis, 104:448 
Interleukin 6 (IL-6) 
in cirrhosis, 104:1492 
in inflammatory bowel disease, 
104:1285 
in predicting mortality in infected cir-
rhotics, 104:1248-tmig 
Interleukins, in chronic colitis (rat), 
104:47 
Intermediate filaments, in intermediate 
cells of Cajal, 104:343 
Interstitial cells of Cajal, in human small 
intestine, 104:343 
Intestinal fluid, a-chain protein in, 
104:278-cr 
Intestines 
developing, bacterial toxins and, 
104:916-srr, 104:916 
interleukin 1 in, 104:749 
macromolecular uptakes in, 104:622-srr 
mast cells in (rat), 104:122 
motility of 
uyadrenergic drugs and (rat), 104:819 
IL - lß action on (rat), 104:377 
permeability hypothesis and, 104:1588-
tmig, 104:1627, 104:1848-e 
regulatory peptides and, 104:1205-e 
in sarcoidosis, 104:947-c 
transplantation of, 104:675-ceig 
Intra-abdominal pressure, in cirrhosis, 
104:222 
Intragastric distribution, cigarette smok-
ing effects on, 104:410 
Intrahepatic cholestasis of pregnancy, 
ursodeoxycholic acid for, 104:660-
ss 
Intraluminal manometry, deglutitive 
tongue action and, 104:152 
In vitro cell aggregation, in Crohn's dis-
ease, 104:772 
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Ionomycin, membrane transport and, 
104:1796 
Ion transport 
bacterial toxin interaction with devel-
oping intestine and, 104:916-srr, 
104:916 
EH EC 0157:H7 and (rabbit), 104:467 
endothelin 1 and (rat), 104:1328 
Iron status 
aspartate aminotransferase and, 
104:665-c 
in genetic hemochromatosis link with 
liver cancer, 104:2-tmig, 228 
hydrogen peroxide damage and (rat), 
104:780 
Irritable bowel syndrome (IBS), so-
matostatin in, 104:1248-tmig 
Ischemia, of small bowel, Buerger's dis-
ease presenting as, 104:1192-cr 
Isosorbide-5-mononitrate, for variceal 
bleeding, 104:1247-tmig, 104:1460 
Itching, in cholestasis, 104:1-tmig, 
104:244 
Japan 
familial adenomatous polyposis in, 
104:954-tmig, 104:989 
HCV RNA and, 104:672-tmig 
Jaundice 
sulindac-associated hepatic injury and, 
104:569 
vitamin E absorption in, 104:1587-tmig 
J chain, in proliferating B cells, 104:278-cr 
Jejunum 
bile salts in, passive absorption of (rat), 
104:165 
bovine growth hormone in (transgenic 
mice), 104:973 
celiac disease and, 104:1263 
a-chain protein in, 104:278-cr 
cytochrome P450 in (rat), 104:1611 
EM523 and (dog), 104:1320 
ethanol in (rabbit), 104:361 
growth, phytohemagglutinin lectin and 
(rat), 104:1669 
M cells in (rat), 104:698 
nitric oxide in (dog, human), 104:398 
pseudo-obstruction and, 104:1398 
JO 1784, cysteamine duodenal ulcers and 
(rat), 104:427 
K + 
bacterial toxin interaction with devel-
oping intestine and, 104:916-srr 
in duodenal bicarbonate transport (rab-
bit), 104:732 
transport, in human biliary cell lines, 
104:1796 
K + channels, basolateral, in esophageal 
cells (rabbit), 104:417 
Kaposi sarcoma, ileal, 104:1822-cr 
Ketotifen 
ethanol-induced microvascular injury 
and (rabbit), 104:361 
in mast cell activation (rat), 104:122 
Kidneys 
in agenesis of dorsal pancreas, 
104:1183-cr 
in cirrhosis, 104:884, 104:1139, 
104:1886-c, 104:1892-c 
cyclosporin A and, 104:519 
endothelin in, 104:1485 
in hepatic cirrhosis, 104:931 -e, 104:931 
indomethacin and, 104:869 
low-dose Captopril and, 104:588 
transplantation of 
HCV RNA levels after, 104:671-tmig 
hepatitic C virus infection and, 
104:862 
Kodak Ektachem lipase, absence of false 
elevations with, 104:l580-c 
Korea, alcoholism in, 104:664-br 
K-ras mutations, in colorectal cancer, 
104:1044 
KT1-32, for chronic colitis (rat), 104:47 
ß-Lactoglobulin, celiac disease and, 
104:1263 
Lactulose 
intestinal permeability to, 104:1588-
tmig, 104:1627 
in pneumatosis cystoides intestinalis, 
104:392 
Lamellae, muscle, intermediate cells of 
Cajal and, 104:343 
Lamina propria 
in collagenous colitis, 104:906-cr, 
104:906 
in cryptosporidiosis (pig), 104:440 
interleukin 1 in, 104:749 
interleukin 2 in (rat), 104:964 
mucosal histamine content and, 
104:1057 
Laminin, in IGF-I receptor expression 
(rat), 104:1705 
Laparoscopy, in appendectomy, 104:935-
ss 
Laparotomy, ileus induced by, fedotozine 
in reversal of (rat), 104:724 
Large-droplet fat, in hepatitis C virus 
infection, 104:595 
Large infranuclear inclusion bodies, in 
gastric mucous cells (rat), 104:103 
Large intestine 
NSAID side effects in, 104:1832-srr 
ventromedial hypothalamic lesions and 
DNA synthesis in (rat), 104:475 
Laser photoablation, of Barrett's epithe-
lium, 104:1855-e, 104:1686 
Latitude, anorectal melanoma correlated 
with, 104:174 
L cells, intestinal, ileal proglucagon gene 
expression and (rat), 104:459 
LDQ10 monoclonal antibody, MUC2 
apomucin tandem repeat and 
(mouse), 104:93 
Lectin affinity chromatography, choles-
terol crystallization inhibitor in 
bile and, 104:527 
Lectins, binding of, to glycoconjugates of 
human gastric fundus, 104:1883-br 
Left-sided tumors, in colorectal carci-
noma, 104:57 
Leiomyosarcoma, long-term survival for, 
104:940-ss 
Leucine 
y-aminobutyric acid in liver regenera-
tion and (rat), 104:217 
turnover, in cirrhosis, 104:1858-e, 
104:1712 
Leukocyte function associated antigens 
(LFAs) , in Crohn's disease, 
104:772 
Leukocyte rolling, and firm adhesion in 
microcirculation, 104:310-e 
Leukocytes 
adherence of in mesenteric venules 
(rat), 104:31 
unsticking of, methotrexate in, 104:1-
tmig 
Leukopenia, during cheomtherapy for 
liver cancer, 104:196 
Leukotriene B 4 ( L T B 4 ) , leukocyte-endo-
thelial cell adhesive interactions 
and (rat), 104:31 
Leukotriene D 4 
in chronic colitis (rat), 104:47 
in colitic muscularis mucosae (rabbit), 
104:369 
Leukotrienes, cyclosporin A and (rat), 
104:1507 
Leumedins, colon inflammation and 
(rat), 104:953-tmig, 104:1021 
Lichen planus, interferon alpha-2a ther-
apy and, 104:903-cr 
Life-style factors, colorectal adenomas 
and, 104:1445 
Light microscopy, of endothelin 1 bind-
ing site in liver (rat), 104:1745 
Lipidapheresis, in hyperlipidemic pan-
creatitis, 104:1527-cr, 104:1560-e 
Lipids 
in cholecystitis (rabbit), 104:248 
in gastric mucous cells (rat), 104:103 
in pancreatitis, 104:1527-cr, 104:1560-e 
5-Lipoxygenase inhibitor 
for acetic acid-induced colitis (rat), 
104:1021 
for chronic colitis (rat), 104:47 
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Liquids, intragastric distribution of, ciga-
rette smoking effects on, 104:410 
Liver 
bile duct epithelial cells and (rat), 
104:840 
bile salt clearance and (rat), 104:165 
cachectin/tumor necrosis factor and 
(rat), 104:235 
cancer 
combined modality treatment of, 
104:196 
in genetic hemochromatosis, 104:2-
tmig, 104:228 
hepatitis B virus and, 104:961 
orthotopic liver transplantation for, 
104:317-e 
cells, in hepatitis C virus infection, 
104:595 
cirrhosis 
abdominal pressure and hemody-
namics in, 104:222 
amino acid kinetics in, 104:1858-e, 
104:1712, 104:1886-c 
cancer and, 104:2-tmig 
Captopril and renal function in, 
104:588 
central blood volume in, 104:1878-ss 
cyclosporin A for, 104:519 
cytokines and, 104:1248-tmig 
endothelin in, 104:1485 
first bleeding in, 104:1460 
gastrointestinal hemorrhage and, 
104:1238-c 
glomerular filtration rate in, 104:884 
with hepatitis B, 104:1 1 16 
hyperdynamic circulation in, 
104:l579-c 
interferon alpha for, 104:953-tmig 
interleukin 6 in, 104:1492 
kidneys in, 104:931-e, 104:1892-c 
new strategies needed for treatment 
of, 104:651-e 
NSAID-induced renal dysfunction in, 
104:869 
peripheral arteriovenous shunting in, 
104:1139 
spontaneous bacteral peritonitis in, 
104:954-tmig, 104:1 133 
tumor necrosis factor a in, 104:1492 
cyclosporin A and (rat), 104:1507 
cytochrome P-450 in, 104:203 
disease 
shock enhances translocation of gut 
bacteria in, 104:1587-tmig, 
104:1722 
total parenteral nutrition and, 
104:286-srr 
viral hepatitis and, 104:944-br 
vitamin E deficiency in, 104:1587-
tmig, 104:1727 
endothclin 1 binding site in (rat), 
104:1745 
hepatitis B virus mutations and, 104:263 
hepatitis C virus RNA in, 104:1472 
hydatid cysts and, 104:1452 
injury 
NSAIDs in, 104:569 
propafenone in, 104:1524-cr 
sulindac in, 104:569 
itch, etiology of, 104:1-tmig 
necrosis, activated macrophages in (rat), 
104:1466 
nodular transformation of, 104:616-cr, 
104:759 
pruritis, propofol and, 104:244 
regeneration, y-aminobutyric acid in 
(rat), 104:217 
tauroursodeoxycholic acid effect on cy-
tosolic Ca 2 + in (rat), 104:604 
transplantation, 104:673-ceig 
in combined modality treatment for 
liver cancer, 104:196 
guide to, 104:1233-br 
hepatitis D recurrence after, 104:1122 
for hepatocellular carcinoma, 
104:317-e 
orthotopic, 104:317-e, 104:1122 
Liver/kidney microsome type 1 
in cryptogenic chronic active hepatitis, 
104:1588-tmig, 104:1755, 104:1756 
in hepatitis C virus, 104:1762 
in type II autoimmune hepatitis, 
104:1870-e 
Loss of heterozygosity ( L O H ) , p53 
gene, in ulcerative colitis, 104:1633 
Lower esophageal sphincter ( L E S ) 
central vagal efferent supply to (cat), 
104:1430 
inhibitory junction potentials of (opos-
sum), 104:1439 
neural inhibition of (cat), 104:810 
nitric oxide in relaxation of, 104:656-ss 
Luminal feedback regulation, of pan-
creas (rat), 104:1780 
Lymphocytes 
in acute pancreatitis (rat), 104:1498 
in celiac disease, 104:1263 
in colonic inflammation (rat), 104:759 
Lymphocytic gastritis, Menetrier's dis-
ease and, 104:1310 
Lymphoid follicles, in hepatitis C virus 
infection, 104:595 
Lynch syndromes I and II, hereditary 
nonpolyposis colorectal cancer 
and, 104:1535-srr 
Lysine, biocytin and (rat), 104:75 
Lysolecithin, in cholecystitis (rabbit), 
104:248 
Lysosomal hydrolases, in acute pancre-
atitis, 104:1768 
Lysosomes, in M cells (rat), 104:698 
Mac-1, in Crohn's disease, 104:772 
Macromolecular permeability, gut, in 
pancreatitis (rat), 104:890 
Macromolecular uptakes, in intestine, 
104:622-srr 
Macrophage-derived mucin secreta-
gogue, in inflammatory bowel 
disease, 104:1302 
Macrophages 
activated, in liver necrosis (rat), 
104:1466 
in acute pancreatitis (rat), 104:1498 
in colonic inflammation (rat), 104:759 
Magnetron, in endoscopy (dog), 
104:672-tmig, 104:680, 104:672 
Major histocompatibility antigen 
(MHC)-restricted cytotoxicity, 
in inflammatory bowel disease, 
104:384 
Major histocompatibility complex 
(MHC) class II determinants, in 
M cells (rat), 104:698 
Malabsorption, in liver disease, 
104:1587-tmig, 104:1727 
Mallory body-like material, in hepatitis 
C virus infection, 104:595 
Mannitol, intestinal permeability to, 
104:1588-tmig, 104:1627 ' 
Manometry 
deglutitive tongue action and, 104:152 
of sphincter of Oddi, I04:1243-c 
Massive foveolar hyperplasia and min-
imal inflammation, Menetrier's 
disease and, 104:1310 
Mast cells 
activation of, prostaglandins in inhibi-
tion of (rat), 104:122 
ethanol-induced microvascular injury 
and (rabbit), 104:361 
prostanoids in release of inflammatory 
mediators from, I04:3l4-e 
Matrigel, in IGF-I receptor expression 
(rat), 104:1705 
Mauritius, a-chain disease in, 104:278-cr 
M cells 
endosomal-lysosomal system and la 
expression in (rat), 104:698 
macromolecular transport through, 
104:622-srr 
McNei l -A343, in esophagitis (cat), 
104:810 
Meal, smoking and intragastric distribu-
tion of, 104:410 
Medetomidine, intestinal motility and 
(rat), 104:819 
Medical education, changing, special iza-
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tion of gast roe nterology in Amer-
ica and, 104:7-ceig 
Melanoma, anorectal, 104:174 
Membrane stabilization, by ursodeoxy-
c h o l i c 104:1736 
Membrane transport, in biliary cell lines, 
104:1796 
Menetrier's disease, characterization of, 
104:1310 
Mental retardation, in agenesis of dorsal 
pancreas, 104:1183-cr 
Mepyramine, in Crohn's disease, 
104:1692 
Mercaptides, in ulcerative colitis, 104:802 
Mercapto-fatty acid, in ulcerative colitis, 
104:802 
6-Mercaptopurine, for ulcerative colitis, 
104:326-srr 
Mesalamine, for Crohn's disease, 
104:435, 104:1293 
Mesenteric circulation, nitric oxide in, 
104:896 
Mesenteric venules, leukocyte adherence 
in (rat), 104:31 
Messenger R N A (mRNA) 
cholecystokinin, 104:1092 
a-fetoprotein, 104:256 
gastrin, 104:1092, 104:1099 
insulinlike growth factor, 104:1595 
insulinlike growth factor-binding pro-
tein, 104:1595 
insulinlike growth factor 1, 104:973, 
104:1705 
interleukin 1, 104:749 
interleukin-2Rß, 104:448 
ileal proglucagon, 104:459 
trefoil peptide, 104:12 
Metallothionein, in Wilson's disease, 
104:1566-ss 
Metallothionein I promoter, bovine 
growth hormone gene and (trans-
genic mice), 104:973 
Metaplasia, intestinal, esophageal cancer 
and, 104:510 
[met]-enkephalin 
gallbladder motility and (dog), 104:1680 
in pyloric sphincter (rat), 104:1072 
Methanogenic bacteria, in pneumatosis 
cystoides intestinalis, 104:392 
Methotrexate (MTX) 
in inhibition of white cell stickiness, 
104:1 -tmig 
leukocyte adhesion and (rat), 104:31 
for primary biliary cirrhosis, 104:652-e 
Methylene blue, in lower esophageal 
sphincter relaxation, 104:657-ss 
N'-Methylhistamine, elimination, from 
gastric mucosa (rabbit), 104:1013 
Metranidazole, for pouchitis, 104:981 
Mexico, traveler's diarrhea in, 104:671-
tmig, 104:709 
Microcirculation, leukocytes and, 
104:310-e 
Microtiuorimetry, pH, regulation in 
esophageal epithelial cells and 
(rabbit), 104:185 
Micronodular hyperplasia, peptic ulcer 
disease and, 104:1356 
Microorganisms, infectious, in Crohn's 
disease, 104:351 
Microsomal Ca2 +-translocase inhibitor, 
tauroursodeoxycholic acid and 
(rat), 104:604 
Microspectrofluorometry, taurourso-
deoxycholic acid effects on cyto-
solic Ca 2 + in isolated hepatocytes 
and (rat), 104:604 
Microvascular injury, jejunal, ethanol-in-
duced (rabbit), 104:361 
Microvillus membrane receptors, bac-
terial toxin binding to, 104:916-srr 
Microwave generator, in endoscopy 
(dog), 104:672-tmig, 104:680, 
104:926-e 
Migrating myoelectric complexes 
fedotozine and (rat), 104:724 
IL- lß action on intestinal motility and 
(rat), 104:377 
Misoprostol, in mast cell activation (rat), 
104:122 
Missense mutations 
in chronic hepatitis B virus infection, 
104:263 
in ulcerative colitis, 104:1633 
Mitomycin C, in experimental colitis 
(rat), 104:1049 
MK-329, cholecystokinin and, 104:1414 
MK-886, for chronic colitis (rat), 104:47 
MMS-68, in inflammatory bowel disease, 
104:1302 
Mobilferrin, as calreticulin homologue 
(rat), 104:1700 
Mononitrates, for variceal bleeding, 
104:1247-tmig, 104:1460 
Mononuclear cells 
granulomalike aggregates of, in Crohn's 
disease, 104:772 
lamina propria 
interleukin 1 in, 104:749 
interleukin 2 in (rat), 104:964 
Morphine 
ileus and (rat), 104:724 
spinal, itching and, 104:1-tmig, 104:244 
Mortality rates 
for acute pancreatitis, 104:1165 
for esophageal cancer, 104:1037 
for liver cancer, 104:196 
for sulindac-associated hepatic injury, 
104:569 
for ulcerative colitis, 104:1241-c 
Mosaic differentiation, of human villus 
enterocytes, 104:21 
Motilin 
EM523 and (dog), 104:1320 
gallbladder motility and (dog), 104:1680 
pepsinogen and (guinea pig), 104:1030 
Motion sickness, vection-induced, relief 
of, 104:665-c 
Motoneuronal labeling, colonic vagus 
nerve and (rat), 104:502 
MUC2 apomucin tandem repeat, detec-
tion of (mouse), 104:93 
Mucin 
gallbladder, in cholesterol monohydrate 
crystal growth, 104:1515 
gastric 
gastric acid and, 104:1878-ss 
regulation of synthesis of, 104:1888-c 
Mucosal atrophy, cell kinetics of in 
stomach (rat), 104:796 
Mucosal cells 
hydrogen peroxide damage and (rat), 
104:780 
prostaglandins in (rat), 104:103 
Mucosal healing, transglutaminase and 
(rat), 104:65 
Mucosal protection 
epidermal growth factor in (rat), 
104:1605 
prostanoids in, 104:314-e 
Multinucleation, liver cell, in hepatitis C 
virus infection, 104:595 
Multiple endocrine neoplasia, carci-
noids and, 104:994 
Multivisceral transplantation, history of, 
104:675-ceigxlMuscarinic syn-
apses, JO 1784 and (rat), 104:427 
Muscle contraction, in colitis (rat), 
104:1049 
Muscularis mucosae, colonic, in colitis 
(rabbit), 104:369 
Muscular wasting, cachectin/tumor ne-
crosis factor and (rat), 104:235 
Mycobacteria, in Crohn's disease, 104:351 
Mycoplasma spp., in Crohn's disease, 
104:351 
Myeloperoxidase, in colonic inflamma-
tion (rat), 104:759, 104:1021, 
104:1049 
Myenteric neurons, small intestinal, pre-
synaptic inhibition by adenosine 
on (guinea pig), 104:1420 
Myenteric plexus 
acetylcholine release and (rat), 104:1648 
in chronic intestinal pseudo-obstruc-
tion, 104:1398 
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Myotomy, on proximal duodenum (Aus-
tralian possum), 104:130 
Mz-ChA-1 cells, membrane transport in, 
104:1796 
N a + 
bacterial toxin interaction with devel-
oping intestine and, 104:916-srr 
biocytin and (rat), 104:75 
in cryptosporidiosis (pig), 104:440 
EHEC 0157:H7 and (rabbit), 104:467 
endothelin 1 and (rat), 104:1328 
K + channels and, 104:417 
low-dose Captopril and, 104:588 
octreotide and (rat), 104:575 
pHj regulation in esophageal epithelial 
cells and (rabbit), 104:185 
NADH-cytochrome c reductase, cy-
tochrome P-450 in plasma mem-
brane and, 104:203 
Na-free solutions, in duodenal bicarbon-
ate transport (rabbit), 104:732 
Naloxone 
acupressure and, 104:665-c 
ileus and (rat), 104:724 
tor pruritis, 104:1-tmig 
Naloxone-methiodide, ileus and (rat), 
104:724 
Nasogastric tube, removal of, early oral 
feeding following, 104:324-srr 
Nasopharynx, a-chain protein in, 
104:278-cr 
National Institutes of Health (NIH) , 
gastroenterology and, 104:10-ceig 
Nausea 
endorphins and, 104:665-c 
pregnancy-related, cutaneous electro-
gastrogram and, 104:1569-ss 
Negative feedback regulation, of active 
ileal bile acid transport (guinea 
pig, rat), 104:38 
Nciguan point, for motion sickness, 
104:665-c 
Neonates, scrum bile salt levels in, 
104:165 
Nerves 
calcitonin gene-related peptide and 
(rat), 104:485 
intermediate cells of Cajal and, 104:343 
lower esophageal sphincter and (opos-
sum), 104:1439 
Neural inhibition 
in esophagitis (cat), 104:810 
in intestinal circular muscle, nitric ox-
ide mediation of (dog, human), 
104:398 
Neural projections, from duodenum to 
biliary tract (Australian possum), 
104:130 
Neuroendocrine cells, hyperplasia of, 
trefoil peptide expression and, 
104:12 
Neuroendocrine carcinomas, identifica-
tion of, 104:994 
Neuroendocrine function, calcitonin 
gene-related peptide in (rat), 
104:485 
Neuronal markers, in pyloric sphincter 
(rat), 104:1072 
Neurons 
capsaicin-sensitive (rat), 104:1371 
distension and (rat), 104:834 
Neuropathy 
agenesis of dorsal pancreas and, 
104:H83-cr 
essential mixed cryoglobulinemia and, 
104:273-cr 
gangliosides in prevention of (rat), 
104:1072 
vitamin E deficiency in, 104:1587-tmig, 
104:1727 
Neuropeptide Y (NPY) 
calretinin and, 104:1381 
gallbladder motility and (dog), 104:1680 
in pyloric sphincter (rat), 104:1072 
Neurotensin, gallbladder motility and 
(dog), 104:1680 
Neurotransmitters 
in intestinal muscle (dog, human), 
104:398 
in isolated colon, 104:690 
in lower esophageal sphincter relax-
ation, 104:656-ss 
Neutropenia, chronic inflammatory 
bowel disease and, 104:328-srr 
Neutrophils 
in acute pancreatitis (rat), 104:1498 
adhesion of to endothelial cell mono-
layers, methotrexate effect on, 
104:31 
in alopecia with ulcerative colitis, 
104:1 187-cr 
in colonic inflammation (rat), 104:759 
in inflammatory bowel disease (rat), 
104:953-tmig, 104:1021 
omeprazole and, 104:938-ss 
New South Wales, peptic ulcer in, 
104:1083 
NG-monomethy 1-L-arginin e 
jejunal nitric oxide and (dog, human), 
104:398 
in pancreatic blood flow, 104:672-tmig 
NG-nitro-L-arginine 
calcitonin gene-related peptide and 
(rat), 104:1371 
in inhibitory innervation of colon, 
104:690 
jejunal nitric oxide and (dog, human), 
104:398 
lower esophageal sphincter and (opos-
sum), 104:1439 
in pancreatic blood flow, 104:896 
NG-nitro-L-arginine methyl ester, gas-
tric hyperemia mechanism and 
(rat), 104:114 
Nicotinic agonists, synaptic behavior in 
myenteric neurons and (guinea 
pig), 104:1420 
Nitecapone, bicarbonate secretion and, 
104:825, 104:1409 
Nitrates 
in colonic inflammation (rat), 104:759 
for variceal bleeding, 104:1247-tmig, 
104:1460 
Nitric oxide 
calcitonin gene-related peptide and, in 
capsaicin protection (rat), 104:1371 
in colonic inflammation (rat), 104:759 
in experimental cirrhosis (rat), 104:1750 
gastric hyperemia mechanism and (rat), 
104:114 
in inhibitory innervation of colon, 
104:690 
in jejunum (dog, human), 104:398 
lower esophageal sphincter and, 
104:656-ss, 104:1439 
in pancreatic blood flow control, 
104:672-tmig 
in pancreatic secretion (dog), 104:896 
Nitric oxide synthase, in infantile hy-
pertrophic pyloric stenosis, 
104:658-ss 
Nitrite, in colonic inflammation (rat), 
104:759 
Nitrogen 
cachectin and (rat), 104:235 
in duodenal bicarbonate transport (rab-
bit), 104:732 
Nitroglycerin, apamin and, 104:690 
Nitroprusside, in lower esophageal 
sphincter relaxation, 104:657-ss 
Nodose ganglia, neural projections and 
(Australian possum), 104:130 
Nodular hyperplasia, of liver, 104:616-cr 
Nonadrenergic, noncholinergic 
(NANC) nerves, of lower esoph-




in isolated colon, 104:690 
in lower esophageal sphincter relax-
ation, 104:656-ss 
Non A, non B (NANB) hepatitis 
discovery of, 104:958 
new virus in, l04:335-tmig, 104:556, 
104:640-e 
in renal tranplant recipients, 104:862 
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Nonaspirin, nonsteroidal anti-inflam-
matory drugs, (NANSAIDs) , 
peptic ulcer and, 104:1083 
Nonsense mutations, p53 gene, in ulcer-
ative colitis, 104:1633 
Nonspecific esophageal motility dis-
order ( N E M D ) , characterization 
of, 104:1281 
Nonsteroidal anti-inflammatory drugs 
(NSAIDs) 
in appendicitis, 104:1571-ss 
in hepatic injury, 104:569 
renal dysfunction induced by, in cir-
rhosis, 104:869 
side effects of, 104:1832-srr 
sucrose permeability and, 104:1619 
Nor-binaltorphimine, ileus and (rat), 
104:724 
Nordihydroguaiaretic acid ( N D G A ) , 
acetic acid-induced colitis and 
(rat), 104:1021 
Norepinephrine, in cirrhosis, 104:1485 
Norfloxacin, for spontaneous bacterial 
peritonitis, 104:954-tmig 
North America, alcoholism in, 104:663-
br 
Northern blotting analysis 
albumin and, 104:256 
0t-fetoprotein and, 104:256 
N P C 15669, in inhibition of neutrophil 
recruitment (rat), 104:953-tmig, 
104:1021 
NS4 protein, in hepatitis C virus, 104:580 
Nucleating proteins, cholesterol, 
104:646-e 
Nucleus of the solitary tract, colonic 
vagus nerve and (rat), 104:502 
Nutrition 
cachectin/tumor necrosis factor and 
(rat), 104:235 
colonocyte, 104:802 
Obesity, gallbladder emptying stimuli 
and, 104:1880-ss 
OC.2 antigen, in BDEC lines (rat), 
104:840 
OC.3 antigen, in BDEC lines (rat), 
104:840 
Octanoic acid breath test, carbon-la-
beled, to measure gastric emptying 
of solids, 104:1640 
Octreotide 
distension and, 104:1248-tmig 
for portal hypertension (rat), 104:575 
rectal afferent inhibition by, 104:1390 
O D T - 8 SS, gallbladder motility and (dog), 
104:1680 
(0-3 fatty acids 
in bowel cancer, 104:1239-c 
in enteral nutrition, 104:936-ss 
Omeprazole 
for Barrett's esophagus, 104:1855-e, 
104:1686 
fecal Helicobacter mustelae and (ferret), 
104:86 
in gastric polyposis, 104:1584-c 
neutrophil function and, 104:938-ss 
for peptic ulcer disease, 104:1356 
Oncogenes 
colorectal carcinoma and, 1()4:2-tmig, 
104:57 
immortalized colon cell lines and (rat), 
104:1346 
Oncotic pressure, albumin and a-feto-
protein regulation by, 104:256 
Opiate antagonist, for pruritis, 104:1-
tmig 
Opiates, for diarrhea, 104:671-tmig 
Opie myth, pancreatitis and, l()4:927-e 
Opioid agonist, in reversal of ileus (rat), 
104:724 
K-opioid receptors, fedotozine and (rat), 
104:724 
Opthalmoplegia, vitamin E deficiency 
in, 104:1587-tmig 
Oral rehydration solutions, rice glucose 
polymers in (rat), 104:81 
Organ culture, human fetal stomach in, 
104:492 
Organelles, lipidic, in gastric mucous 
cells (rat), 104:103 
Organizations, gastroenterological, de-
velopment of, 104:9-ceig 
Oropharyngeal propulsive chamber, 
deglutitive tongue action and, 
104:152 
Osmolality 
rice glucose polymers in oral rehydra-
tion solutions and (rat), 104:81 
total parenteral nutrition and (rat), 
104:235 
Ouabain, in duodenal bicarbonate trans-
port (rabbit), 104:732 
OV6 antigen, in BDEC lines (rat), 
104:840 
Ovalbumin, celiac disease and, 104:1263 
Overweight, colorectal adenomas and, 
104:137 
OX6 monoclonal antibody, M cells and 
(rat), 104:698 
OX19 monoclonal antibody, in acute 
pancreatitis (rat), 104:1498 
Oxygen, arteriovenous shunting and, 
104:1139 
Oxygen-dependent metabolic path-
ways, in duodenal bicarbonate 
transport (rabbit), 104:732 
Oxyntic cells, histamine elimination and 
(rabbit), 104:1013 
Oxytocin, gallbladder motility and (dog), 
104:1680 
p53 oncogene 
in colorectal carcinoma, 104:2-tmig, 
104:57 
in ulcerative colitis, 104:1633, 
104:1889-c 
Pacific region, alcoholism in, 104:663-br 
Pancreas 
cancer, MLJC2 apomucin tandem repeat 
and (mouse), 104:93 
dorsal, 104:1182-cr 
duct obstruction in (opossum), 104:853 
exocrine 
FK506 and (rat), 104:1153 
insufficiency of, 104:1255-ceig 
luminal feedback regulation of (rat), 
104:1780 
somatostatin inhibition of secretin in 
(rat), 104:1146 
ileal proglucagon gene expression and 
(rat), 104:459 
nitric oxide in, l04:672-tmig, 104:896 
Pancreas divisum, stenting of, 104:1226-
ss 
Pancreaticojejunostomy, longitudinal, 




cellular kinetics of (rat), 104:1498 
chloroquine in, 104:1768 
damage prevention vs. damage con-
trol in, 104:1216-e 
acute necrotizing (opossum), 104:853 
acute relapsing, after endoscopic 
sphincterotomy, 104:1814-cr 
in agenesis of dorsal pancreas, 
104:1183-cr 
chronic, history of, 104:1255-ceig 
early electron-microscopic acinar cell 
derangements in, I04:1236-c 
gabexate mesilate in, 104:1165 
gestational hyperlipidemic, extracorpo-
real lipid elimination for, 
104:1527-cr, 104:1560-e 
gut permeability in (rat), 104:890 
Opie myth and, 104:927-e 
recurrent, intraluminal pancreatic can-
didiasis presenting as, 104:1532-cr 
in systemic lupus erythematosus, 
104:61 3-cr 
Papillary stenosis, acute relapsing pan-
creatitis as complication of, 
104:1814-cr 
Paraventricular nucleus (PVN), corti-
cotropin-releasing factor in (rat), 
104:716 
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Parietal cell gastrin receptor, cloning of 
(dog), 104:1876-ss 
D-Penicillamine, for primary biliary cir-
rhosis, 104:651-e 
Pentasa. See Mesalamine 
Peplomycin, for esophageal cancer, 
104:953-tmig, 104:1037 
Pepsinogen, secretion, motilin and 
erythromycin in regulation of 
(guina pig), 104:1030 
Peptic ulcer disease 
immune system and, 104:1874-ss 
nonsteroidal anti-inflammatory drugs 
and hospitalization rates of, 
104:1083 
omeprazole for, 104:1356 
Peptide histidine isoleucine (PHI), 
gallbladder motility and (dog), 
104:1680 
Peptide Y Y 
gallbladder motility and (dog), 104:1680 
ileal proglucagon gene expression and 
(rat), 104:459 
phytohemagglutinin lectin exposure and 
(rat), 104:1669 
Peptidoglycan-polysaccharide (PG-
PS), in inflammation (rat), 104:759 
Percutaneous drainage, for hepatic hy-
datosis, 104:1452 
Peripheral blood mononuclear cells 
(PBMCs) 
in hepatitis C virus, 104:580 
in inflammatory bowel disease, 104:384 
Peritoneum, mast cells in (rat), 104:122 
Peritonitis 
ileus induced by, fedotozine in reversal 
of (rat), 104:724 
spontaneous bacterial, 104:954-tmig, 
104:1133 
Permeability, intestinal 
in Crohn's disease, 104:1588-tmig, 
104:1627, 104:1848-e 
marker for, 104:1619 
Peyer's patches, jejunal, M cells in (rat), 
104:698 
PF-5901, in mast cell activation (rat), 
104:122 
p H 
in acute pancreatitis, 104:1768 
bile, gallstone calcification and, 
I04:1885-c 
biocytin and (rat), 104:75 
gastric, fecal Helicobacter mustelae and 
(ferret), 104:86 
intracellular, in esophageal epithelial 
cells (rabbit), 104:185 
Pharyngeal chamber, deglutitive tongue 
action and, 104:152 
Phenanthroline, hydrogen peroxide 
damage and (rat), 104:780 
Phenolphthalein, in diarrhea induction, 
104:1007 
Phentolamine, bicarbonate secretion and 
(rat), 104:825 
Phenylalanine, turnover, in cirrhosis, 
104:1712, 104:1858-e 
Phenylephrine, tauroursodeoxycholic 
acid and (rat), 104:604 
Phloretin, ethanol-induced microvascular 
injury and (rabbit), 104:361 
Phorbol ester, pancreatic FK506 and 
(rat), 104:1153 
Phospholipids 
ethanol and (rat), 104:179 
in gastric mucous cells (rat), 104:103 
gastric surfactant and, 104:179 
Phosphotyrosine antibodies, immortal-
ized colon cell lines and (rat), 
104:1346 
Physiological buffer, pH[ regulation in 
esophageal epithelial cells and 
(rabbit), 104:185 
Physiology, gastrointestinal, early Ameri-
can studies of, 104:6-ceig 
Phytohemagglutinin lectin, in mucosal 
growth (rat), 104:1669 
Pigment stones, gallbladder motility and, 
104:563 
Piroxicam, endothelin 1 and (rat), 
104:1328 
Plasma membrane, hepatocyte, cy-
tochrome P-450 in, 104:203 
Plasmid-encoding adhesion factors, 
EI I HC 0157:117 and (rabbit), 
104:467 
Plastic, in culture medium, in IGF-1 re-
ceptor expression (rat), 104:1705 
Platelet-activating factor (PAF) 
in chronic colitis (rat), 104:47 
endothelin 1 and (rat), 104:1328 
leukocyte-endothelial cell adhesive in-
teractions and (rat), 104:31 
prostaglandins and (rat), 104:122 
Pneumatosis cystoides intestinalis, hy-
drogen metabolism in, 104:392 
Pneumonia, in agenesis of dorsal pan-
creas, 104:1183-cr 
Point mutations, p53 gene, in ulcerative 
colitis, 104:1633 
Policy and Position Statement 
Credentialing, 104:1563 
Gastroenterology board recertification: 
a mandate for continuing scholar-
ship, 104:1221 
Hospital credentialing standards for 
physicians who perform endosco-
pies, 104:1563 
Recertification in gastroenterology, 
104:1220 
Polidocanol, for coagulation of bleeding 
ulcers (dog), 104:680 
Poly amines 
gastric damage and (rat), 104:65 
in gastrointestinal tract, 104:1577-br 
Polyethylene glycol ( P E G ) , in pancre-
atitis (rat), 104:890 
Polymerase chain reaction (PCR) 
familial adenomatous polyposis and, 
104:954-tmig, 104:989 
hepatitis B virus and, 104:263, 104:549 
hepatitis C virus and, 104:272-cr, 
104:549, 104:556 
hepatitis E virus and, 104:556 
HLA class I I genes and, 104:741 
K-ras mutations and, 104:57, 104:1044 
Polymers, in a-chain disease, 104:278-cr 
Polyposis 
gastric, omeprazole in, 104:1584-c 
juvenile atypical, 104:910-cr 
Polysaccharide-free diet, for pneumato-
sis cystoides intestinalis, 104:392 
Portal hypertension 
bacterial translocation in, 104:1587-
tmig, 104:1722 
in cirrhosis, 104:222 
in focal nodular hyperplasia of liver, 
104:616-cr 
isosorbide-5-mononitrate in, 104:1460 
octreotide for (rat), 104:575 
Portal-systemic nephropathy, hepatic 
cirrhosis and, 104:931-e 
Portal tracts, aggregates in, in hepatitis C 
virus infection, 104:595 
Portosystemic shunts, indocyanine green 
as measure of, 104:884 
Postcapillary venules, leukocyte adher-
ence in (rat), 104:31 
Postoperative feeding, liquid vs. solid 
fuel, 104:324-srr 
Potassium chloride 
in Crohn's disease, 104:1692 
gallbladder motility and, 104:563 
muscle contraction in colitis and (rat), 
104:1049 
splanchic vascular hyporeactivity and 
(rat), 104:1750 
Potassium conductance, esophageal cell 
K + channels and (rabbit), 104:417 
Potential difference, in duodenal bicar-
bonate transport (rabbit), 104:732 
Pouchitis 
inflammatory infiltrate in, 104:981 
problem with, 104:1209-e 
Powell, Don. W., M.D., 104:1249 
Powell Tuck Index, for Crohn's disease, 
104:1064 
Precapillary connections, arteriovenous 
shunting and, 104:1139 
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Precore mutations, in chronic hepatitis B 
virus infection, 104:263 
Prednisone 
for collagenous colitis, 104:906-cr 
for cryptogenic chronic active hepatitis, 
104:1757 
for primary biliary cirrhosis, 104:651-e 
Pregnancy 
first trimester, gastric myoelectrical 
activity, in, 104:1569-ss 
fulminant hepatitis in, 104:556 
gestational hyperlipidemic pancreatitis 
in, 104:1527-cr, 104:1560-e 
intrahepatic cholestasis of, 104:660-ss 
Prelysosomes, in M cells (rat), 104:698 
Presynaptic inhibition, by adenosine 
(guinea pig), 104:1420 
Primary biliary cirrhosis 
cyclosporin A for, 104:519 
new strategies needed for treatment of, 
104:651-e 
Primary sclerosing cholangitis, urso-
deoxycholic acid for, 104:941-ss 
Proctocolectomy, anal transition zone 
and, 104:514 
Progastrin, in colorectal carcinoma, 
104:1099 
Proglucagon gene, ileal, expression of 
(rat), 104:459 
Propafenone, hepatotoxicity of, 
104:1524-cr 
Propofol, for pruritis, 104:1 -tmig, 104:244 
Propranolol, for variceal bleeding, 
104:1247-tmig, 104:1460 
Prostacyclin,endothelin 1 and (rat), 
104:1328 
Prostaglandin E 2 ( P G E 2 ) 
coli tic muscularis mucosae and (rabbit), 
104:369 
in cryptosporidiosis (pig), 104:440 
in duodenal bicarbonate secretion, 
104:732, 104:1409 
interleukin 2 and (rat), 104:964 
in mast cell activation (rat), 104:122 
pepsinogen and (guinea pig), 104:1030 
Prostaglandin F 2 a ( P G E 2 ) , colitic mus-
cularis mucosae and (rabbit), 
104:369 
Prostaglandin I 2 (PGI 2 ), in cholecystitis 
(rabbit), 104:248 
Prostaglandins 
calcitonin gene-related peptide and 
(rat), 104:1371 
gastric hyperemia mechanism and (rat), 
104:114 
in gastric mucous cells (rat), 104:103 
IL - l ß action on intestinal motility and 
(rat), 104:377 
indomethacin and, 104:869 
in inhibition of mast cell activation 
(rat), 104:122 
Prostanoids 
in acute cholecystitis (rabbit), 104:248 
in cryptosporidiosis (pig), 104:440 
in gastric mucous cells (rat), 104:103 
in inflammatory mediator release from 
mast cells, 104:314-e 
Protamine, basic fibroblast growth factor 
and (frog), 104:1337 
Protease, in inhibition of Toxin A intes-
tinal effects (rat), 104:1108 
Protease inhibitor, in acute pancreatitis, 
104:1165 
Protein, cachectin/tumor necrosis factor 
and (rat), 104:235 
Protein cross-linking, gastric damage 
and (rat), 104:65 
Prothrombin time 
arteriovenous shunting and, 104:1139 
in spontaneous bacterial peritonitis, 
104:954-tmig 
Proton pump inhibitor, in hypochlorhy-
dria (ferret), 104:86 
Proulcerogenic mediators, in mast cells 
(rat), 104:122 
pS2 peptide, gene expression, in gastro-
intestinal epithelial cells in inflam-
matory bowel disease, 104:12 
Pseudo-obstruction, chronic intestinal, 
in infants and children, 104:1398 
Psyllium, for secretory diarrhea, 104:1007 
Puerto Rico, alcoholism in, 104:663-br 
Pulmonary arterial hypertension, focal 
nodular hyperplasia of liver and, 
I04:616-cr 
Purine analogues, for ulcerative colitis, 
104:325-srr 
Purine nucleoside Phosphorylase, sinu-
soidal endothelial cell damage and 
(rat), 104:1466 
Purpura, essential mixed cryoglobulin-
emia and, 104:273-cr 
Putrescine 
y-aminobutyric acid in liver regenera-
tion and (rat), 104:217 
transglutaminase and (rat), 104:65 
Pyloric sphincter, neuropathy in, pre-
vention of (rat), 104:1072 
Pyloric stenosis, infantile hypertrophic, 
nitric oxide synthase in, 104:658-ss 
Pyrilamine, gastric hyperemia mecha-
nism and (rat), 104:114 
Pyrogallol, in lower esophageal sphincter 
relaxation, 104:657-ss 
Quinine, esophageal cell K + channels and 
(rabbit), 104:417 
Race 
anorectal melanoma and, 104:174 
colorectal adenomas and, 104:1445 
Radiography,in Crohn's disease, 104:351 
Radioscintigraphy, of nonspecific 
esophageal motility disorder, 
104:1281 
Ranitidine, for peptic ulcer disease, 
104:1356 
ras oncogenes 
in colorectal cancer, 104:2-tmig, 
104:57, 104:1044 
immortalized colon cell lines and (rat), 
104:1346 
Raynaud's syndrome, essential mixed 
cryoglobulinemia and, 104:273-cr 
8 6 R b , membrane transport and, 104:1796 
Receptor-mediated transport capacity, 
in a-chain disease, 104:278-cr 
Recertification, in gast roe nterology, 
104:1220-paps, 104:1221-paps 
Recombinant proteins, hepatitis C virus, 
104:580 
Rectal afferent inhibition, by octreotide, 
104:1390 
Rectosigmoid neoplasia, in ulcerative 
colitis, 104:666-c 
Rectum 
anal transition zone and, 104:514 
colonic vagus nerve and (rat), 104:502 
Red blood cell membranes, ursodeoxy-
cholate in stabilization of, 104:1736 
Red kidney bean phytohemagglutinin 
lectin, in mucosal growth (rat), 
104:1669 
Reducing agents, colonocyte nutrition 
and, 104:802 
Reducing sulfur compounds, in ulcera-
tive colitis, 104:802 
Regulatory peptides, intestinal growth 
and, 104:1205-e 
Regulatory volume decrease, K + chan-
nels and, 104:417 
Renal duplication, in agenesis of dorsal 
pancreas, 104:1183-cr 
Renin 
arteriovenous shunting and, 104:1139 
in cirrhosis, 104:1485 
octreotide and (rat), 104:575 
Restraint-stress, 4-hour, ulcers and (rat), 
104:427 
Restriction enzyme digestion, Ki-ras 
codon 12 mutations and, 104:57 
Retrograde intragastric movement, cig-
arette smoking and, 104:410 
Reverse transcription, of HCV RNA, 
104:877 
Review process, for GASTROENTEROL-
OGY, 104:1252-e 
Rice glucose polymers, in oral rehydra-
tion solutions (rat), 104:81 
Right-sided tumors, in colorectal carci-
noma, 104:57 
rlRAP, for chronic colitis (rat), 104:47 
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R N A 
in enteral nutrition, 104:936-ss 
hepatitis C virus, i()4:671-tmig, 
104:862, 104:877, 104:1472 
RP55778, for chronic colitis (rat), 104:47 
Saccharomyces boulardii, in inhibition of 
Toxin A intestinal effects (rat), 
104:1108 
Saline 
intragastric hypertonic, in gastric hy-
peremia (rat), 104:114 
isotonic, y-aminobutyric acid in liver 
regeneration and (rat), 104:217 
Salmonella typhimurium, epithelial sig-
nal transduction mechanisms for 
invasion and, l()4:326-srr 
Sarcoidosis, intestinal involvement in, 
104:947-c 
SC 19220, IL - lß action on intestinal mo-
tility and (rat), 104:377 
Scleroderma, nonspecific esophageal mo-
tility disorder and, 104:1281 
Scopolamine, pancreatic FK506 and 
(rat), 104:1 153 
Secretin 
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CENTRAL BLOOD VOLUME IN CIRRHOSIS 
Henriksen J, Bendtsen F, Gerbes A } et al. (Departments of Clini-
cal Physiology and Hepatology, Hvidovre Hospital, Univer-
sity of Copenhagen, Copenhagen, Denmark; Department of 
Internal Medicine and Endocrinology, Herlev Hospital, 
University of Copenhagen, Copenhagen, Denmark; and De-
partment of Medicine II Klinikum Grosshadern, Ludwig 
Maximilian University, Munich, Germany). Estimated cen-
tral blood volume in cirrhosis: relationship to sympathetic 
nervous activity, ß-adrenergic blockade and atrial natri-
uretic factor. Hepatology 1992;16:1163-1170. 
The dispute between the "overflow" and "underfill" the-
ories of early pathophysiology in cirrhosis shows no signs of 
early resolution. Regardless of what the initial events might 
be, however, in the more advanced stages of cirrhosis the 
clinical picture suggests a maldistribution of blood volume. 
The authors of the present article have been interested in 
determining the volume of blood contained in the heart, 
lungs, and central arterial tree, which they have termed the 
estimated central blood volume (ECBV). The present study 
from Copenhagen is an attempt to quantify the E C B V and 
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to look for correlations with sympathetic nervous activity, 
atrial natriuretic factor (ANF) levels and the effects of 
adrenergic blockade on these parameters. This is one of a 
series of studies by a group of investigators that has had a 
long-term interest in the hemodynamic abnormalities asso-
ciated with cirrhosis. 
Nineteen patients (17 male) with biopsy-proven cirrhosis 
were studied and compared with 16 subjects (12 male) with 
normal hepatic function. Nine other subjects served as con-
trols for assay of arterial and renal venous catecholamines. 
The cirrhotic patients were roughly equally divided into 
Child-Turcotte groups A - B and C. Patients and controls 
underwent catheterization of the right atrium as well as the 
hepatic and renal veins. An arterial catheter was positioned 
at the bifurcation of the aorta. Total plasma volume, whole 
blood volume, and cardiac output were determined as previ-
ously described (Gastroenterology 1989;97:1506-1513) by 
the same group of investigators. The hepatic gradient was 
determined by direct measurement. 
The ECBV is calculated by multiplying the cardiac output 
by the mean indicator transit time. The latter figure is the 
mean time of indicator sojourn in the central vascular bed. 
This is estimated from the time-weighted area under the 
arterial indicator curve following an injection of ^ - l a -
belled albumin at the junction of the inferior vena cava and 
the right atrium with arterial sampling at the level of the 
aortic bifurcation. Plasma catecholamines and ANF levels 
were determined by standard methods (Gut 1984;25:1034-
1043; Liver 1986;6:361-368). 
There was a significant difference in the ECBV between 
cirrhotics (22.9 mL/kg) and controls (27.2 m.L/kg). As 
would be expected from this finding, the mean central cir-
culation time was less in the cirrhotic patients (14.0 sec-
onds ± 4 . 1 ) compared with the controls (20.0 seconds ± 
6.1). There was an inverse relationship between the hepatic 
gradient, which reflects portal pressure, and the ECBV. The 
cirrhotics had an increase in total plasma volume along with 
a decrease in mean arterial blood pressure and systemic vas-
cular resistance. Arterial plasma norepinephrine (but not 
epinephrine) levels were significantly increased in the pa-
tients (3.08 vs. 1.36 nmol/L). There was an inverse correla-
tion between norepinephrine levels and ECBV. Plasma 
ANF levels were normal in both patients and controls, ß-
blockade caused the expected decrease in heart rate and car-
diac output while the central circulation time increased, 
thereby leaving the E C B V unchanged. Arterial catechol-
amines rose after propranolol administration, but there was 
no correlation with the ECBV. 
Comment. The main conclusions of this article are that at some 
stage of cirrhosis, not necessarily at its inception, there is a maldis-
tribution of blood with a relative deficiency of plasma volume in 
the ECBV associated with a rise in the levels of norepinephrine. 
The authors suggest that these changes are causally related, because 
there was a strong inverse relationship between ECBV and renal 
vein catecholamines. There are several other studies confirming 
the elevation of norepinephrine in cirrhosis (Lancet 1986;(Oct): 
939-992) and (N Engl J Med 1982;309:1152-1 157). The authors 
contend that this central underfilling contributes directly to the 
enhanced sympathetic activity with renal sympathetic overactivity 
causing reduced renal blood flow and increased sodium and water 
retention in established cirrhosis. This interpretation is in keeping 
with the authors' previous work in which an hypothesis is sug-
gested for the early changes in cirrhosis. They have postulated an 
initial decrease in peripheral resistance (of unknown cause), which 
then leads to peripheral sequestration of fluid, a decrease in ECBF, 
under perfusion of baro- and volume receptors with consequent 
increase in sympathetic activity and associated salt and water re-
tention. Although this is an attractive theory, there are a number 
of factors it does not explain such as the role of other salt-retaining 
hormones and the surprising lack of effect of ß-blockade on the 
ECBV in spite of major hemodynamic shifts. This might raise the 
question of how definite an entity the ECBV is because its determi-
nation is based on catheter placement, which must be somewhat 
arbitrary. Rector (Gastroenterology 1988;95:1658-1663) reported 
that left atrial size was actually greater in cirrhotics, whereas both 
left and right atrial pressures were similar in cirrhotics with and 
without ascites. This would appear to excuse the heart of any "cen-
tral underfilling" in cirrhosis. Because there is no evidence of dif-
ferences in pulmonary vascular capacity, this leaves only the aorta 
as a possible site for the decreased ECBV. One could also point out 
that there is no present explanation for the initial decrease in pe-
ripheral resistance postulated by the authors, but this, perhaps, is 
not too different from the situation with the classic "overflow" 
theory in which the early message from the liver to the kidney 
remains a postulate rather than a measurement. 
The lack of any demonstrable role for the ANF in this theory is 
surprising. ANF has been reported to be low, normal, and high in 
cirrhosis. Unless these discrepancies are all due to technical errors 
(unlikely), this suggests that ANF levels may fluctuate at various 
stages of cirrhosis, and our separation into "compensated" and 
"decompensated" is too crude to detect these changes. A recent 
study by Angeli et al. (ITepatology 1992; 16:1 389-1394) has shown 
several subgroups of cirrhotics in which ANF levels correlate with 
various hormone patterns. The present study shows convincingly 
that plasma- and blood-volume distribution in cirrhosis is abnor-
mal. Most physicians will have little argument with the findings 
showing that cirrhotics have a high cardiac output, low peripheral 
resistance, and too much blood in the peripheral vessels and 
splanchnic bed with too little in the large central arteries, because 
al! these determinations fit well w'th clinical observation. 
Whether increased sympathetic tone is an etiological factor in 
these changes, however, remains at best an hypothesis. 
J . G . S W E E T I N G , M . D . 
Reply. We would like to thank Dr. Sweeting for his comments 
on our report regarding central blood volume and sympathetic 
overactivity in cirrhosis (Hepatology 1992;16:1163-1170). We 
fully agree that the dispute between the "overflow" and "under-
fill" theories of early pathophysiology in cirrhosis seems to have 
no easy solution. 
Dr. Sweeting raises the question of how definite an entity the 
central and arterial blood volume (ECBV) is and excludes the 
heart of any "central underfilling" based on a previous paper by 
Rector and Hossak (Gastroenterology 1988;95:1658-1663). 
ECBV (determined according to the kinetic theory as mean transit 
time in the central circulation multiplied by cardiac output) is the 
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blood volume in the heart cavities, lungs, and central arterial tree, 
i.e., the volume of blood contained within the arterial tree up to 
points that are temporally equidistant from the heart to the aortic 
bifurcation. The aortic bifurcation is arbitrary, but this was applied 
in cirrhotics as well as in controls. Rector and Hossak (Gastroenter-
ology 1988;95:1658-1663) and Rector et al. (Gastroenterology 
1990;99:766-779) have reported increased left atrial diameters in 
patients with cirrhosis and a nonsignificant increase in right ven-
tricle diameter. However, taking a close look at their values ob-
tained by echocardiography the average increase in the cardiac 
chambers is only 16 mL compared with controls (Hepatology 
1991; 13:1261). This is indeed a low difference compared with our 
decrease in ECBV (300 mL). Moreover, it should be recalled that 
volume detection by echocardiography has a relatively low accu-
racy (Am J Cardiol 1983;52:1249-1257). Thus, if the presence of 
ascites changes the configuration of the heart, volume measure-
ment by standard echocardiographic procedures may not be 
correct (Hepatology 1990;11:662-667). Altogether, the findings 
referred to by Dr. Sweeting do not provide convincing points 
against our data. 
ANF plasma concentrations are the result of both release and 
clearance (Life Sei 1990;47:1173-1180). Thus, alterations of A N F 
clearance by the liver and splanchnic circulation (Hepatology 
1992;16:790-793) may counteract changes of ANF release in cir-
rhosis, resulting in unchanged plasma concentrations. Further-
more, the missing relation to ANF in our study may in part be due 
to the fact that 58% of the patients received diuretics, which are 
likely to influence the circulating levels of ANF. Moreover, the 
ANF data by Angeli et al. (Hepatology 1992;16:1389-1394) men-
tioned by Dr. Sweeting support our contention of a marked under-
filling in decompensated cirrhosis. 
We agree that there is no good present explanation for the de-
crease in systematic vascular resistance, but a number of potent 
vasodilators are increased in patients with cirrhosis (Lancet 
1984;1:1480-1483; Gut 1988,29:1167-1 172; J Hepatol 1991;12: 
118-123). 
Finally, the enhanced sympathetic nervous activity is, most 
likely, a consequence of central and arterial underfilling, not an 
etiological factor. 
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